Efficacy of Gomutra-Haritaki and Guda-Haritaki in the management of Jalodara With Special Reference Ascites of Hepatic Cirrhosis Origin - An open labeled randomized comparative clinical trial.
Not Applicable
Not yet recruiting
- Conditions
- Health Condition 1: K703- Alcoholic cirrhosis of liver
- Registration Number
- CTRI/2021/03/032209
- Lead Sponsor
- Government Akhandanand Ayurved Mahavidyalaya
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Not Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Patients having ascites due to Hepatic Cirrhosis origin
Chronicity less than 1 year
Uncomplicated cases of Jalodara
Patients willing to participate in trial
Exclusion Criteria
Patients having age below 18 years and above 60 years
AIDS
Congestive Cardiac Failure
Congestive Pericarditis
Other Cardiac Disorders
TB
Nephrotic Syndrome
Grade 4 prolapsed hemorrhoid
Carcinoma
Hepatic Encephalopathy
Diabetic ketoacidosis
Hepatitis B
Acute and Chronic Renal Failure
Acute Pancreatitis
History of Recurrent Gastric and Esophageal Variceal Rupture and Hematemesis
Associated with any other serious systemic disease or complications which leads to fatal conditions will be excluded
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Result will be assessed on the basis of relief signs and symptoms of Jalodara after 6 weeks.Timepoint: Result will be assessed on the basis of relief signs and symptoms of Jalodara after 6 weeks.
- Secondary Outcome Measures
Name Time Method By comparing the effect of both drugs in the management of jalodaraTimepoint: 6 weeks